484 related articles for article (PubMed ID: 21352331)
1. 5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer.
Hirata Y; Koga S; Fukui N; Yu A; Koshida S; Kosaka Y; Kurokawa T; Moriwaki S
J Dermatol; 2011 Aug; 38(8):748-54. PubMed ID: 21352331
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
3. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
[TBL] [Abstract][Full Text] [Related]
5. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation.
Kolde G; Rowe E; Meffert H
Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095
[No Abstract] [Full Text] [Related]
6. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
[TBL] [Abstract][Full Text] [Related]
7. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
9. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
10. Dye laser photodynamic therapy for Bowen's disease in a patient with epidermodysplasia verruciformis.
Sunohara M; Ozawa T; Morimoto K; Harada T; Ishii M; Fukai K
Osaka City Med J; 2012 Dec; 58(2):77-82. PubMed ID: 23610850
[TBL] [Abstract][Full Text] [Related]
11. [The wider application of photodynamic therapy in dermatology].
Thissen MR; Kuijpers DI; Neumann HA
Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
[TBL] [Abstract][Full Text] [Related]
12. Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme.
de Haas ER; Sterenborg HJ; Neumann HA; Robinson DJ
Arch Dermatol; 2007 Feb; 143(2):264-5. PubMed ID: 17310011
[No Abstract] [Full Text] [Related]
13. Red light laser photodynamic therapy of Bowen's disease.
Parlette EC
J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
[No Abstract] [Full Text] [Related]
14. Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study.
Ibbotson SH; Ferguson J
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):235-9. PubMed ID: 22971187
[TBL] [Abstract][Full Text] [Related]
15. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
[TBL] [Abstract][Full Text] [Related]
17. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy.
Stables GI; Stringer MR; Robinson DJ; Ash DV
Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836
[TBL] [Abstract][Full Text] [Related]
18. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
19. Huge Bowen's disease: a pitfall of topical photodynamic therapy.
Park JY; Kim SK; Cho KH; Kim YC
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):546-8. PubMed ID: 24284109
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen's disease.
Mizutani K; Akita Y; Yanagishita T; Kimura M; Tanaka T; Kinoshita Y; Nakano A; Tamada Y; Matsumoto Y; Watanabe D
Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):142-6. PubMed ID: 22548396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
